A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors.
Clinical trial NCT00816400 · COMPLETED
Trial details
- NCT number
- NCT00816400
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-02
- Primary completion
- 2012-01-19
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.